Medivation, Astellas launch trials in prostate, breast cancers
December 04, 2013 at 16:32 PM EST
Medivation Inc. and partner Astellas Pharma Inc. started a pair of clinical trials of their cancer-fighting drug enzalutamide — one in prostate cancer, the other in breast cancer — that could expand the use of the capsules...